4FU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Alsea SAB de CV

Watchlist Manager

Watchlist

Price: 1.9656 EUR 1.67% Market Closed

Market Cap: €1.6B

A	Alsea SAB de CV XMUN:4FU	MX
R	Regeneron Pharmaceuticals Inc XMUN:RGO	US
T	Takeda Pharmaceutical Co Ltd F:TKDA	JP
	Calbee Inc OTC:CBCFF	JP
A	Adecco Group AG XMUN:ADI1	CH
G	Garmin Ltd XMUN:GEY	CH
	OSE Immunotherapeutics SA OTC:ORPOF	FR

Profitability Summary

Alsea SAB de CV's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

70%

Gross Margin is Increasing

69% > 69%

Healthy Operating Margin

10%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

9% > 10%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

3% > 2%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

12% > 15%

Positive ROE

19%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.